company background image
RHHB.F logo

Roche Holding OTCPK:RHHB.F Stock Report

Last Price

US$288.23

Market Cap

US$228.4b

7D

-6.5%

1Y

-0.3%

Updated

22 Nov, 2024

Data

Company Financials +

RHHB.F Stock Overview

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. More details

RHHB.F fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance0/6
Financial Health3/6
Dividends5/6

Roche Holding AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Roche Holding
Historical stock prices
Current Share PriceCHF 288.23
52 Week HighCHF 368.43
52 Week LowCHF 243.42
Beta0.15
11 Month Change-17.88%
3 Month Change-19.49%
1 Year Change-0.27%
33 Year Change-30.04%
5 Year Change-5.19%
Change since IPO130.59%

Recent News & Updates

Recent updates

Shareholder Returns

RHHB.FUS PharmaceuticalsUS Market
7D-6.5%-1.4%0.3%
1Y-0.3%10.8%31.1%

Return vs Industry: RHHB.F underperformed the US Pharmaceuticals industry which returned 10.8% over the past year.

Return vs Market: RHHB.F underperformed the US Market which returned 31.1% over the past year.

Price Volatility

Is RHHB.F's price volatile compared to industry and market?
RHHB.F volatility
RHHB.F Average Weekly Movement7.3%
Pharmaceuticals Industry Average Movement9.6%
Market Average Movement6.2%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: RHHB.F has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: RHHB.F's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1896103,605Thomas Schineckerwww.roche.com

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas.

Roche Holding AG Fundamentals Summary

How do Roche Holding's earnings and revenue compare to its market cap?
RHHB.F fundamental statistics
Market capUS$228.42b
Earnings (TTM)US$11.88b
Revenue (TTM)US$67.75b

19.1x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RHHB.F income statement (TTM)
RevenueCHF 60.58b
Cost of RevenueCHF 15.43b
Gross ProfitCHF 45.16b
Other ExpensesCHF 34.54b
EarningsCHF 10.62b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)13.33
Gross Margin74.54%
Net Profit Margin17.53%
Debt/Equity Ratio104.8%

How did RHHB.F perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

72%

Payout Ratio